| 摘要 |
Therapeutic compositions for the treatment of viral hepatitis B (HBV) and hepatitis C (HCV) comprise antistreptokinase and antistreptolysine antibodies and/or tranexamic acie. Three antibodies against: polymerase, plasmin activators and fibrin are found in the blood of hepatitis C infected patients.
|
